StockData
Artivion, Inc. logo

Artivion, Inc. (AORT) stock

AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/305% below fair value
$18.27−0.20 (-1.08%)

Close on Nov 17, 2026Market cap $890.78MP/E –Yield –

Artivion price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Artivion's price to sales ratio was 2.1× on Nov 11, 2026, against 4.8× a year earlier. Over the last 5 years it ranged from 1.5× to 4.8×, with a median of 2.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.1×−2.6
2025Dec 31, 20254.7×+1.5
2024Dec 31, 20243.2×+1.0
2023Dec 29, 20232.2×+0.7
2022Dec 30, 20221.5×−1.3
2021Dec 31, 20212.8×−0.6
2020Dec 31, 20203.5×−0.2
2019Dec 31, 20193.7×−0.5
2018Dec 31, 20184.2×+0.6
2017Dec 29, 20173.6×+0.1
2016Dec 30, 20163.5×+1.3
2015Dec 31, 20152.1×−0.1
2014Dec 31, 20142.2×+0.0
2013Dec 31, 20132.2×+0.9
2012Dec 31, 20121.3×+0.2
2011Dec 30, 20111.1×−0.2
2010Dec 31, 20101.4×–

More Artivion figures

See a number that looks wrong?